Eurocine Vaccines hereby announces that Flerie Invest AB has acquired shares in the company and holds above 10 % of the shares in the company. Flerie Invest AB holds approximately 12.55 % of the votes and capital. Further, Eurocine Vaccines announces that Formue Nord Markedsneutral A/S has decreased its holdings to approximately 3.09 % of the votes and capital.

Flerie Invest AB has acquired approximately 12.55 % of the votes and capital in Eurocine Vaccines. Flerie Invest AB is an investment company within the biotechnology and life science sector with offices in Stockholm and London. The company was founded in 2010 by Thomas Eldered, co-founder of Recipharm.

Further, Eurocine Vaccines announces that Formue Nord Markedsneutral A/S has decreased its holdings to approximately 3.09 % of the votes and capital.